nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
|
Xu, Peng |
|
|
89 |
2 |
p. 183-196 |
artikel |
2 |
Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis
|
Yan, Mingrui |
|
|
89 |
2 |
p. 173-181 |
artikel |
3 |
Correction to: Anticancer potential of metformin: focusing on gastrointestinal cancers
|
Khezri, Mohammad rafi |
|
|
89 |
2 |
p. 283 |
artikel |
4 |
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota
|
Liu, Junmin |
|
|
89 |
2 |
p. 243-253 |
artikel |
5 |
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in mice
|
Kiesel, Brian F. |
|
|
89 |
2 |
p. 231-242 |
artikel |
6 |
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
|
Dosne, Anne-Gaëlle |
|
|
89 |
2 |
p. 151-164 |
artikel |
7 |
Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2
|
Chen, Lei |
|
|
89 |
2 |
p. 217-229 |
artikel |
8 |
Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment
|
Secombe, Kate R. |
|
|
89 |
2 |
p. 275-281 |
artikel |
9 |
Lost in third space: altered tyrosine-kinase inhibitor pharmacokinetics in a patient with malignant ascites
|
Krens, Stefanie D. |
|
|
89 |
2 |
p. 271-274 |
artikel |
10 |
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
|
Reda, Manon |
|
|
89 |
2 |
p. 197-208 |
artikel |
11 |
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
|
Moy, Ryan H. |
|
|
89 |
2 |
p. 255-265 |
artikel |
12 |
Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma
|
Wen, Xi-zhi |
|
|
89 |
2 |
p. 209-215 |
artikel |
13 |
Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies
|
Karami, Elmira |
|
|
89 |
2 |
p. 165-172 |
artikel |
14 |
Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement
|
Condorelli, Annalisa |
|
|
89 |
2 |
p. 267-270 |
artikel |